Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 6

Treatment options and patient perspectives in the management of fibromyalgia: future trends

Authors Kim Lawson

Published 5 December 2008 Volume 2008:4(6) Pages 1059—1071

DOI https://dx.doi.org/10.2147/NDT.S3468

Review by Single-blind

Peer reviewer comments 4

Kim Lawson

Biomedical Research Centre, Sheffield Hallam University, Faculty of Health and Wellbeing, Sheffield, UK

Abstract: Fibromyalgia (FM) is a common, complex, and difficult to treat chronic widespread pain disorder, which usually requires a multidisciplinary approach using both pharmacological and non-pharmacological (education and exercise) interventions. It is a condition of heightened generalized sensitization to sensory input presenting as a complex of symptoms including pain, sleep dysfunction, and fatigue, where the pathophysiology could include dysfunction of the central nervous system pain modulatory systems, dysfunction of the neuroendocrine system, and dysautonomia. A cyclic model of the pathophysiological processes is compatible with the interrelationship of primary symptoms and the array of postulated triggers associated with FM. Many of the molecular targets of current and emerging drugs used to treat FM have been focused to the management of discrete symptoms rather than the condition. Recently, drugs (eg, pregabalin, duloxetine, milnacipran, sodium oxybate) have been identified that demonstrate a multidimensional efficacy in this condition. Although the complexity of FM suggests that monotherapy, non-pharmacological or pharmacological, will not adequately address the condition, the outcomes from recent clinical trials are providing important clues for treatment guidelines, improved diagnosis, and condition-focused therapies.

Keywords: fibromyalgia, pain, sleep dysfunction, fatigue, exercise, pharmacological treatments

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities

Sanna V, Pala N, Dessì G, Manconi P, Mariani A, Dedola S, Rassu M, Crosio C, Iaccarino C, Sechi M

International Journal of Nanomedicine 2014, 9:4935-4951

Published Date: 23 October 2014

A study of longitudinal data examining concomitance of pain and cognition in an elderly long-term care population

Burfield AH, Wan TTH, Sole ML, Cooper JW

Journal of Pain Research 2012, 5:61-70

Published Date: 23 March 2012

Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer

Guo LG, Fan L, Ren JF, Pang Z, Ren Y, Li J, Wen Z, Qian Y, Zhang L, Ma H, Jiang X

International Journal of Nanomedicine 2012, 7:1449-1460

Published Date: 19 March 2012

Carbon-covered magnetic nanomaterials and their application for the thermolysis of cancer cells

Yang Xu, Meena Mahmood, Ashley Fejleh, et al

International Journal of Nanomedicine 2010, 5:167-176

Published Date: 11 March 2010

Current migraine management – patient acceptability and future approaches

Arnaud Fumal, Jean Schoenen

Neuropsychiatric Disease and Treatment 2008, 4:1043-1057

Published Date: 5 December 2008

Mycophenolate mofetil for myasthenia gravis: a clear and present controversy

Chad Heatwole, Emma Ciafaloni

Neuropsychiatric Disease and Treatment 2008, 4:1203-1209

Published Date: 5 December 2008

Treatment of Lennox-Gastaut syndrome: overview and recent findings

Kenou van Rijckevorsel

Neuropsychiatric Disease and Treatment 2008, 4:1001-1019

Published Date: 5 December 2008

Sub-Tenon′s triamcinolone for post-partum Purtscher′s-like retinopathy

Jeffrey Olson, Behnaz Rouhani, Naresh Mandava

Clinical Ophthalmology 2008, 2:195-198

Published Date: 7 March 2008